
Sign up to save your podcasts
Or


In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. David Gershenson (Twitter: @RareOvarCancers) from MD Anderson Cancer Center in Houston, Texas to talk about the management of rare ovarian tumors in ovarian cancers, including mucinous, clear cell, and small cell. They discuss metastatic vs. primary mucinous tumors, the role of HIPEC in the treatment of advanced disease, as well as genomic profiling. Look out for IJGC's upcoming pdocast with Dr. Gershenson on updates on management of low-grade ovarian tumors.
By BMJ Group5
2323 ratings
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. David Gershenson (Twitter: @RareOvarCancers) from MD Anderson Cancer Center in Houston, Texas to talk about the management of rare ovarian tumors in ovarian cancers, including mucinous, clear cell, and small cell. They discuss metastatic vs. primary mucinous tumors, the role of HIPEC in the treatment of advanced disease, as well as genomic profiling. Look out for IJGC's upcoming pdocast with Dr. Gershenson on updates on management of low-grade ovarian tumors.

37 Listeners

52 Listeners

5 Listeners

8 Listeners

5 Listeners

3 Listeners

2 Listeners

3 Listeners

8 Listeners

38 Listeners

14 Listeners

1 Listeners

51 Listeners

0 Listeners

6 Listeners

14 Listeners

3 Listeners

3 Listeners

23 Listeners